data ae; /* Adverse events */
   length aebodsys aedecod $ 80 ap bp $ 12;
   input aebodsys $80. / aedecod $80. / acount bcount ap bp sort_bodysys;
   datalines;
Metabolic and nutritional
Peripheral edema
32 23 (82.1%) (63.9%) 1
Metabolic and nutritional
Hyperlipidemia
18 17 (46.2%) (47.2%) 1
Metabolic and nutritional
Hyperkalemia
12 15 (30.8%) (41.7%) 1
Metabolic and nutritional
Creatinine increased
16 10 (41.0%) (27.8%) 1
Metabolic and nutritional
Hyperglycemia
12 12 (30.8%) (33.3%) 1
Metabolic and nutritional
Acidosis
8 12 (20.5%) (33.3%) 1
Metabolic and nutritional
Edema
10 10 (25.6%) (27.8%) 1
Metabolic and nutritional
Hypophosphatemia
11 9 (28.2%) (25.0%) 1
Metabolic and nutritional
Healing abnormal
10 7 (25.6%) (19.4%) 1
Metabolic and nutritional
Hypokalemia
7 5 (17.9%) (13.9%) 1
Metabolic and nutritional
Hypercholesteremia
8 2 (20.5%) (5.6%) 1
Metabolic and nutritional
Hypomagnesemia
5 5 (12.8%) (13.9%) 1
Metabolic and nutritional
Weight gain
6 4 (15.4%) (11.1%) 1
Metabolic and nutritional
Hypocalcemia
6 3 (15.4%) (8.3%) 1
Metabolic and nutritional
Hypoglycemia
3 4 (7.7%) (11.1%) 1
Metabolic and nutritional
Hyponatremia
3 4 (7.7%) (11.1%) 1
Metabolic and nutritional
Weight loss
3 2 (7.7%) (5.6%) 1
Metabolic and nutritional
Hypercalcemia
1 3 (2.6%) (8.3%) 1
Metabolic and nutritional
Hyperphosphatemia
2 2 (5.1%) (5.6%) 1
Metabolic and nutritional
Lactic dehydrogenase increased
4 0 (10.3%) (0.0%) 1
Metabolic and nutritional
Alkalosis
2 0 (5.1%) (0.0%) 1
Metabolic and nutritional
Dehydration
1 1 (2.6%) (2.8%) 1
Metabolic and nutritional
Electrolyte abnormality
0 2 (0.0%) (5.6%) 1
Metabolic and nutritional
Alkaline phosphatase increased
0 1 (0.0%) (2.8%) 1
Body as a whole
Fever
15 15 (38.5%) (41.7%) 2
Body as a whole
Pain
18 12 (46.2%) (33.3%) 2
Body as a whole
Abdominal pain
14 11 (35.9%) (30.6%) 2
Body as a whole
Asthenia
12 9 (30.8%) (25.0%) 2
Body as a whole
Headache
12 5 (30.8%) (13.9%) 2
Body as a whole
Infection
10 6 (25.6%) (16.7%) 2
Body as a whole
Chest pain
7 7 (17.9%) (19.4%) 2
Body as a whole
Lymphocele
4 8 (10.3%) (22.2%) 2
Body as a whole
Overdose
9 3 (23.1%) (8.3%) 2
Body as a whole
Back pain
7 4 (17.9%) (11.1%) 2
Body as a whole
Chills
4 3 (10.3%) (8.3%) 2
Body as a whole
Abscess
2 4 (5.1%) (11.1%) 2
Body as a whole
Ascites
3 2 (7.7%) (5.6%) 2
Body as a whole
Generalized edema
3 2 (7.7%) (5.6%) 2
Body as a whole
Sepsis
1 4 (2.6%) (11.1%) 2
Body as a whole
Drug level increased
1 2 (2.6%) (5.6%) 2
Body as a whole
Face edema
2 1 (5.1%) (2.8%) 2
Body as a whole
Malaise
2 1 (5.1%) (2.8%) 2
Body as a whole
Neck pain
1 2 (2.6%) (5.6%) 2
Body as a whole
Accidental injury
1 1 (2.6%) (2.8%) 2
Body as a whole
Cellulitis
0 2 (0.0%) (5.6%) 2
Body as a whole
Lab test abnormal
1 1 (2.6%) (2.8%) 2
Body as a whole
Moniliasis
1 1 (2.6%) (2.8%) 2
Body as a whole
Neoplasm
0 2 (0.0%) (5.6%) 2
Body as a whole
Non-specified drug reaction
1 1 (2.6%) (2.8%) 2
Body as a whole
Pelvic pain
1 1 (2.6%) (2.8%) 2
Body as a whole
Retroperitoneal hemorrhage
1 1 (2.6%) (2.8%) 2
Body as a whole
Traumatic hematoma
2 0 (5.1%) (0.0%) 2
Body as a whole
Abdomen enlarged
1 0 (2.6%) (0.0%) 2
Body as a whole
Accidental overdose
1 0 (2.6%) (0.0%) 2
Body as a whole
Allergic reaction
1 0 (2.6%) (0.0%) 2
Body as a whole
Chest pain substernal
0 1 (0.0%) (2.8%) 2
Body as a whole
Flu syndrome
1 0 (2.6%) (0.0%) 2
Body as a whole
Gangrene
0 1 (0.0%) (2.8%) 2
Body as a whole
Hernia
1 0 (2.6%) (0.0%) 2
Body as a whole
Injection site pain
0 1 (0.0%) (2.8%) 2
Body as a whole
Medication error
0 1 (0.0%) (2.8%) 2
Body as a whole
Mucous membrane disorder
0 1 (0.0%) (2.8%) 2
Body as a whole
Peritonitis
1 0 (2.6%) (0.0%) 2
Digestive system
Diarrhea
18 14 (46.2%) (38.9%) 3
Digestive system
Nausea
14 11 (35.9%) (30.6%) 3
Digestive system
Vomiting
9 11 (23.1%) (30.6%) 3
Digestive system
Constipation
9 10 (23.1%) (27.8%) 3
Digestive system
Abdominal distension
12 6 (30.8%) (16.7%) 3
Digestive system
Dyspepsia
9 3 (23.1%) (8.3%) 3
Digestive system
Liver function tests abnormal
7 3 (17.9%) (8.3%) 3
Digestive system
Anorexia
7 2 (17.9%) (5.6%) 3
Digestive system
Oral moniliasis
3 3 (7.7%) (8.3%) 3
Digestive system
Dysphagia
4 1 (10.3%) (2.8%) 3
Digestive system
Flatulence
4 1 (10.3%) (2.8%) 3
Digestive system
Gastroesophageal reflux disease
3 2 (7.7%) (5.6%) 3
Digestive system
Rectal disorder
3 2 (7.7%) (5.6%) 3
Digestive system
Gastrointestinal disorder
3 1 (7.7%) (2.8%) 3
Digestive system
Gastrointestinal physical finding
2 1 (5.1%) (2.8%) 3
Digestive system
Ileus
2 1 (5.1%) (2.8%) 3
Digestive system
Blood in stool
0 2 (0.0%) (5.6%) 3
Digestive system
Colitis
2 0 (5.1%) (0.0%) 3
Digestive system
Faecal occult blood positive
1 1 (2.6%) (2.8%) 3
Digestive system
Gastritis
1 1 (2.6%) (2.8%) 3
Digestive system
Gastroenteritis
1 1 (2.6%) (2.8%) 3
Digestive system
Gastrointestinal moniliasis
1 1 (2.6%) (2.8%) 3
Digestive system
Mouth ulceration
1 1 (2.6%) (2.8%) 3
Digestive system
Cholangitis
0 1 (0.0%) (2.8%) 3
Digestive system
Duodenitis
0 1 (0.0%) (2.8%) 3
Digestive system
Gastrointestinal hemorrhage
0 1 (0.0%) (2.8%) 3
Digestive system
Gi neoplasia
1 0 (2.6%) (0.0%) 3
Digestive system
Gum hyperplasia
0 1 (0.0%) (2.8%) 3
Digestive system
Hematemesis
0 1 (0.0%) (2.8%) 3
Digestive system
Hemorrhagic gastritis
1 0 (2.6%) (0.0%) 3
Digestive system
Hepatosplenomegaly
0 1 (0.0%) (2.8%) 3
Digestive system
Hiatal hernia
1 0 (2.6%) (0.0%) 3
Digestive system
Increased appetite
1 0 (2.6%) (0.0%) 3
Digestive system
Intestinal ulcer
0 1 (0.0%) (2.8%) 3
Digestive system
Pain rectal
1 0 (2.6%) (0.0%) 3
Digestive system
Pancreatitis
0 1 (0.0%) (2.8%) 3
Digestive system
Rectal hemorrhage
0 1 (0.0%) (2.8%) 3
Digestive system
Stomatitis
0 1 (0.0%) (2.8%) 3
Digestive system
Stools abnormal
1 0 (2.6%) (0.0%) 3
Digestive system
Tongue disorder
0 1 (0.0%) (2.8%) 3
Cardiovascular system
Hypertension
24 16 (61.5%) (44.4%) 4
Cardiovascular system
Hypotension
9 12 (23.1%) (33.3%) 4
Cardiovascular system
Tachycardia
9 9 (23.1%) (25.0%) 4
Cardiovascular system
Hypervolemia
8 4 (20.5%) (11.1%) 4
Cardiovascular system
Cardiovascular physical finding
4 3 (10.3%) (8.3%) 4
Cardiovascular system
Cardiomegaly
2 3 (5.1%) (8.3%) 4
Cardiovascular system
Tachycardia sinus
4 1 (10.3%) (2.8%) 4
Cardiovascular system
Bradycardia
1 3 (2.6%) (8.3%) 4
Cardiovascular system
Cardiovascular disorder
0 4 (0.0%) (11.1%) 4
Cardiovascular system
Deep thrombophlebitis
3 1 (7.7%) (2.8%) 4
Cardiovascular system
Hemorrhage
1 3 (2.6%) (8.3%) 4
Cardiovascular system
Hypovolemia
2 2 (5.1%) (5.6%) 4
Cardiovascular system
Vascular disorder
2 2 (5.1%) (5.6%) 4
Cardiovascular system
Aneurysm
1 2 (2.6%) (5.6%) 4
Cardiovascular system
Arterial anomaly
1 2 (2.6%) (5.6%) 4
Cardiovascular system
Postural hypotension
1 2 (2.6%) (5.6%) 4
Cardiovascular system
Ventricular extrasystoles
2 1 (5.1%) (2.8%) 4
Cardiovascular system
Ventricular tachycardia
2 1 (5.1%) (2.8%) 4
Cardiovascular system
Atrial arrhythmia
2 0 (5.1%) (0.0%) 4
Cardiovascular system
Congestive heart failure
0 2 (0.0%) (5.6%) 4
Cardiovascular system
Electrocardiogram abnormal
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Occlusion
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Palpitation
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Pericardial effusion
2 0 (5.1%) (0.0%) 4
Cardiovascular system
Pulmonary embolus
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Pulmonary hypertension
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Thrombosis
2 0 (5.1%) (0.0%) 4
Cardiovascular system
Ventricular fibrillation
1 1 (2.6%) (2.8%) 4
Cardiovascular system
Angina pectoris
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Arterial thrombosis
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Atrial fibrillation
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Cerebral hemorrhage
1 0 (2.6%) (0.0%) 4
Cardiovascular system
Cerebral ischemia
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Intracranial hemorrhage
1 0 (2.6%) (0.0%) 4
Cardiovascular system
Migraine
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Pallor
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Peripheral vascular disorder
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Phlebitis
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Shock
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Sinus bradycardia
1 0 (2.6%) (0.0%) 4
Cardiovascular system
Subarachnoid hemorrhage
1 0 (2.6%) (0.0%) 4
Cardiovascular system
Supraventricular extrasystoles
1 0 (2.6%) (0.0%) 4
Cardiovascular system
Supraventricular tachycardia
0 1 (0.0%) (2.8%) 4
Cardiovascular system
Valvular heart disease
0 1 (0.0%) (2.8%) 4
Urogenital system
Kidney tubular necrosis
24 18 (61.5%) (50.0%) 5
Urogenital system
Urinary tract infection
9 10 (23.1%) (27.8%) 5
Urogenital system
Hematuria
6 7 (15.4%) (19.4%) 5
Urogenital system
Hydronephrosis
3 8 (7.7%) (22.2%) 5
Urogenital system
Dysuria
3 5 (7.7%) (13.9%) 5
Urogenital system
Urinary tract disorder
2 6 (5.1%) (16.7%) 5
Urogenital system
Acute kidney failure
6 1 (15.4%) (2.8%) 5
Urogenital system
Bladder pain
4 3 (10.3%) (8.3%) 5
Urogenital system
Urinary frequency
1 4 (2.6%) (11.1%) 5
Urogenital system
Albuminuria
3 1 (7.7%) (2.8%) 5
Urogenital system
Metrorrhagia
3 1 (7.7%) (2.8%) 5
Urogenital system
Urinary retention
1 3 (2.6%) (8.3%) 5
Urogenital system
Kidney fibrosis
2 1 (5.1%) (2.8%) 5
Urogenital system
Nocturia
1 2 (2.6%) (5.6%) 5
Urogenital system
Oliguria
0 3 (0.0%) (8.3%) 5
Urogenital system
Toxic nephropathy
0 3 (0.0%) (8.3%) 5
Urogenital system
Urinary incontinence
0 3 (0.0%) (8.3%) 5
Urogenital system
Urinary urgency
1 2 (2.6%) (5.6%) 5
Urogenital system
Breast pain
2 0 (5.1%) (0.0%) 5
Urogenital system
Dysmenorrhea
1 1 (2.6%) (2.8%) 5
Urogenital system
Impotence
2 0 (5.1%) (0.0%) 5
Urogenital system
Penis disorder
2 0 (5.1%) (0.0%) 5
Urogenital system
Scrotal edema
1 1 (2.6%) (2.8%) 5
Urogenital system
Uterine hemorrhage
0 2 (0.0%) (5.6%) 5
Urogenital system
Vaginal hemorrhage
1 1 (2.6%) (2.8%) 5
Urogenital system
Vaginal moniliasis
1 1 (2.6%) (2.8%) 5
Urogenital system
Breast engorgement
1 0 (2.6%) (0.0%) 5
Urogenital system
Cystitis
0 1 (0.0%) (2.8%) 5
Urogenital system
Fibrocystic breast
1 0 (2.6%) (0.0%) 5
Urogenital system
Kidney cortex necrosis
0 1 (0.0%) (2.8%) 5
Urogenital system
Kidney pain
1 0 (2.6%) (0.0%) 5
Urogenital system
Nephritis
0 1 (0.0%) (2.8%) 5
Urogenital system
Ovarian cyst
0 1 (0.0%) (2.8%) 5
Urogenital system
Prostatic disorder
1 0 (2.6%) (0.0%) 5
Urogenital system
Pyelonephritis
0 1 (0.0%) (2.8%) 5
Urogenital system
Pyuria
1 0 (2.6%) (0.0%) 5
Urogenital system
Testis disorder
1 0 (2.6%) (0.0%) 5
Urogenital system
Urination impaired
0 1 (0.0%) (2.8%) 5
Urogenital system
Urine abnormality
1 0 (2.6%) (0.0%) 5
Urogenital system
Uterine disorder
0 1 (0.0%) (2.8%) 5
Urogenital system
Vaginitis
1 0 (2.6%) (0.0%) 5
Respiratory system
Dyspnea
17 10 (43.6%) (27.8%) 6
Respiratory system
Cough increased
10 8 (25.6%) (22.2%) 6
Respiratory system
Pulmonary physical finding
11 6 (28.2%) (16.7%) 6
Respiratory system
Upper respiratory infection
6 7 (15.4%) (19.4%) 6
Respiratory system
Pneumonia
6 4 (15.4%) (11.1%) 6
Respiratory system
Pharyngitis
6 2 (15.4%) (5.6%) 6
Respiratory system
Asthma
3 4 (7.7%) (11.1%) 6
Respiratory system
Lung edema
5 2 (12.8%) (5.6%) 6
Respiratory system
Rhinitis
3 4 (7.7%) (11.1%) 6
Respiratory system
Epistaxis
1 4 (2.6%) (11.1%) 6
Respiratory system
Pleural effusion
3 2 (7.7%) (5.6%) 6
Respiratory system
Lung disorder
2 1 (5.1%) (2.8%) 6
Respiratory system
Respiratory failure
2 1 (5.1%) (2.8%) 6
Respiratory system
Atelectasis
1 1 (2.6%) (2.8%) 6
Respiratory system
Hyperventilation
1 1 (2.6%) (2.8%) 6
Respiratory system
Lung infiltration nos
2 0 (5.1%) (0.0%) 6
Respiratory system
Apnea
0 1 (0.0%) (2.8%) 6
Respiratory system
Bronchitis
0 1 (0.0%) (2.8%) 6
Respiratory system
Chronic obstructive airways disease
1 0 (2.6%) (0.0%) 6
Respiratory system
Emphysema
1 0 (2.6%) (0.0%) 6
Respiratory system
Hemoptysis
1 0 (2.6%) (0.0%) 6
Respiratory system
Hiccup
1 0 (2.6%) (0.0%) 6
Respiratory system
Hypoxia
1 0 (2.6%) (0.0%) 6
Respiratory system
Pleural disorder
0 1 (0.0%) (2.8%) 6
Respiratory system
Pneumothorax
0 1 (0.0%) (2.8%) 6
Respiratory system
Respiratory anomaly
0 1 (0.0%) (2.8%) 6
Respiratory system
Respiratory distress syndrome
0 1 (0.0%) (2.8%) 6
Respiratory system
Sinusitis
1 0 (2.6%) (0.0%) 6
Hemic and lymphatic system
Anemia
24 24 (61.5%) (66.7%) 7
Hemic and lymphatic system
Leukopenia
15 12 (38.5%) (33.3%) 7
Hemic and lymphatic system
Thrombocytopenia
9 7 (23.1%) (19.4%) 7
Hemic and lymphatic system
Ecchymosis
3 2 (7.7%) (5.6%) 7
Hemic and lymphatic system
Leukocytosis
2 2 (5.1%) (5.6%) 7
Hemic and lymphatic system
Polycythemia
2 2 (5.1%) (5.6%) 7
Hemic and lymphatic system
Neutropenia
1 2 (2.6%) (5.6%) 7
Hemic and lymphatic system
Pancytopenia
1 1 (2.6%) (2.8%) 7
Hemic and lymphatic system
Coagulation disorder
0 1 (0.0%) (2.8%) 7
Hemic and lymphatic system
Coagulation time increased
0 1 (0.0%) (2.8%) 7
Hemic and lymphatic system
Disseminated intravascular coagulation
1 0 (2.6%) (0.0%) 7
Hemic and lymphatic system
Erythrocytes abnormal
1 0 (2.6%) (0.0%) 7
Hemic and lymphatic system
Iron deficiency anemia
0 1 (0.0%) (2.8%) 7
Hemic and lymphatic system
Lymphadenopathy
1 0 (2.6%) (0.0%) 7
Hemic and lymphatic system
Lymphedema
1 0 (2.6%) (0.0%) 7
Hemic and lymphatic system
Macrocytic anemia
1 0 (2.6%) (0.0%) 7
Nervous system
Tremor
9 9 (23.1%) (25.0%) 8
Nervous system
Insomnia
9 5 (23.1%) (13.9%) 8
Nervous system
Dizziness
6 7 (15.4%) (19.4%) 8
Nervous system
Paresthesia
3 6 (7.7%) (16.7%) 8
Nervous system
Hypesthesia
4 2 (10.3%) (5.6%) 8
Nervous system
Agitation
2 2 (5.1%) (5.6%) 8
Nervous system
Anxiety
3 1 (7.7%) (2.8%) 8
Nervous system
Depression
4 0 (10.3%) (0.0%) 8
Nervous system
Somnolence
3 1 (7.7%) (2.8%) 8
Nervous system
Confusion
1 2 (2.6%) (5.6%) 8
Nervous system
Nervousness
2 1 (5.1%) (2.8%) 8
Nervous system
Abnormal/changed behavior
2 0 (5.1%) (0.0%) 8
Nervous system
Amnesia
1 0 (2.6%) (0.0%) 8
Nervous system
Aphasia
0 1 (0.0%) (2.8%) 8
Nervous system
Cns neoplasia
0 1 (0.0%) (2.8%) 8
Nervous system
Convulsion
1 0 (2.6%) (0.0%) 8
Nervous system
Delusions
1 0 (2.6%) (0.0%) 8
Nervous system
Dementia
1 0 (2.6%) (0.0%) 8
Nervous system
Guillain barre syndrome
0 1 (0.0%) (2.8%) 8
Nervous system
Hostility
0 1 (0.0%) (2.8%) 8
Nervous system
Hypertonia
0 1 (0.0%) (2.8%) 8
Nervous system
Hypotonia
1 0 (2.6%) (0.0%) 8
Nervous system
Manic depressive reaction
1 0 (2.6%) (0.0%) 8
Nervous system
Neuropathy
0 1 (0.0%) (2.8%) 8
Nervous system
Psychosis
1 0 (2.6%) (0.0%) 8
Nervous system
Speech disorder
0 1 (0.0%) (2.8%) 8
Nervous system
Vertigo
0 1 (0.0%) (2.8%) 8
Skin and appendages
Pruritus
6 4 (15.4%) (11.1%) 9
Skin and appendages
Acne
4 4 (10.3%) (11.1%) 9
Skin and appendages
Rash
3 3 (7.7%) (8.3%) 9
Skin and appendages
Sweating
4 2 (10.3%) (5.6%) 9
Skin and appendages
Herpes simplex
3 2 (7.7%) (5.6%) 9
Skin and appendages
Hirsutism
1 4 (2.6%) (11.1%) 9
Skin and appendages
Skin disorder
3 1 (7.7%) (2.8%) 9
Skin and appendages
Erythema
0 3 (0.0%) (8.3%) 9
Skin and appendages
Herpes zoster
0 3 (0.0%) (8.3%) 9
Skin and appendages
Skin discoloration
1 2 (2.6%) (5.6%) 9
Skin and appendages
Alopecia
2 0 (5.1%) (0.0%) 9
Skin and appendages
Fungal dermatitis
2 0 (5.1%) (0.0%) 9
Skin and appendages
Skin benign neoplasm
1 1 (2.6%) (2.8%) 9
Skin and appendages
Skin ulcer
0 2 (0.0%) (5.6%) 9
Skin and appendages
Angioedema
0 1 (0.0%) (2.8%) 9
Skin and appendages
Dry skin
1 0 (2.6%) (0.0%) 9
Skin and appendages
Leukoderma
1 0 (2.6%) (0.0%) 9
Skin and appendages
Maculopapular rash
1 0 (2.6%) (0.0%) 9
Skin and appendages
Nail disorder
1 0 (2.6%) (0.0%) 9
Skin and appendages
Pruritic rash
0 1 (0.0%) (2.8%) 9
Skin and appendages
Skin hypertrophy
0 1 (0.0%) (2.8%) 9
Skin and appendages
Urticaria
1 0 (2.6%) (0.0%) 9
Skin and appendages
Vesiculobullous rash
1 0 (2.6%) (0.0%) 9
Adverse event assoc.w.misc. factors
Local reaction to procedure
25 22 (64.1%) (61.1%) 10
Adverse event assoc.w.misc. factors
Allergic reaction other than drug
2 0 (5.1%) (0.0%) 10
Musculoskeletal system
Arthralgia
10 5 (25.6%) (13.9%) 11
Musculoskeletal system
Bone pain
2 1 (5.1%) (2.8%) 11
Musculoskeletal system
Muscle cramp
3 0 (7.7%) (0.0%) 11
Musculoskeletal system
Myalgia
2 1 (5.1%) (2.8%) 11
Musculoskeletal system
Arthrosis
1 1 (2.6%) (2.8%) 11
Musculoskeletal system
Joint disorder
1 1 (2.6%) (2.8%) 11
Musculoskeletal system
Myasthenia
1 1 (2.6%) (2.8%) 11
Musculoskeletal system
Osteoporosis
0 2 (0.0%) (5.6%) 11
Musculoskeletal system
Intervertebral disc protrusion
0 1 (0.0%) (2.8%) 11
Musculoskeletal system
Leg cramps
1 0 (2.6%) (0.0%) 11
Musculoskeletal system
Musculoskeletal stiffness
1 0 (2.6%) (0.0%) 11
Endocrine system
Cushings syndrome
2 3 (5.1%) (8.3%) 12
Endocrine system
Diabetes mellitus
4 1 (10.3%) (2.8%) 12
Endocrine system
Parathyroid disorder
2 1 (5.1%) (2.8%) 12
Endocrine system
Diabetic acidosis
1 1 (2.6%) (2.8%) 12
Endocrine system
Adrenal cortex insufficiency
0 1 (0.0%) (2.8%) 12
Endocrine system
Diabetic coma
1 0 (2.6%) (0.0%) 12
Endocrine system
Glycosuria
1 0 (2.6%) (0.0%) 12
Endocrine system
Hyperthyroidism
0 1 (0.0%) (2.8%) 12
Endocrine system
Hypothyroidism
1 0 (2.6%) (0.0%) 12
Endocrine system
Thyroid carcinoma
1 0 (2.6%) (0.0%) 12
Endocrine system
Thyroid disorder
1 0 (2.6%) (0.0%) 12
Special senses
Conjunctivitis
2 0 (5.1%) (0.0%) 13
Special senses
Ear pain
1 1 (2.6%) (2.8%) 13
Special senses
Tinnitus
1 1 (2.6%) (2.8%) 13
Special senses
Abnormal vision
0 1 (0.0%) (2.8%) 13
Special senses
Deafness
1 0 (2.6%) (0.0%) 13
Special senses
Ear disorder
1 0 (2.6%) (0.0%) 13
Special senses
Eye disorder
1 0 (2.6%) (0.0%) 13
Special senses
Keratitis
1 0 (2.6%) (0.0%) 13
Special senses
Lacrimation disorder
1 0 (2.6%) (0.0%) 13
Special senses
Otitis media
0 1 (0.0%) (2.8%) 13
Special senses
Photophobia
1 0 (2.6%) (0.0%) 13
Special senses
Retinal disorder
0 1 (0.0%) (2.8%) 13
;